Although the two curves did not reach statistical significance in the dataset from Chen et al. possibly due to the overrepresentation of patients carrying EGFR mutations, which correlated with a limited number of patients in the cluster exhibiting the NRF2 signature and the shortest OS ( p value = 0.064), the trend was consistent.
← all excerpts
Integrative analysis of KEAP1/NFE2L2 alterations across 3600+ tumors reveals an NRF2 expression signature as a prognostic biomarker in cancer.
1
—
—